ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,308.15
1.17%
Dow Jones
39,908.00
0.88%
US Dollar vs MXN
16.684
-0.97%
Brent Oil
82.655
0.13%
Bitcoin
66,358.80
7.82%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. IceCure Medical Ltd (ICCM)

  7. IceCure Medical Ltd (ICCM) Noticias

ICCM IceCure Medical Ltd

1.20
0.08 (7.14%)
Fuera de horario
Última actualización: 15:09:58
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
IceCure Medical Ltd ICCM NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.08 7.14% 1.20 15:09:58
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.13 1.13 1.21 1.20 1.12
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
07/5/202407:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/5/202407:30PRNUSIndependent Study Results in Japan Demonstrate Zero (0%)..
15/4/202407:35PRNUSIceCure Medical Reports Final ICE3 Breast Cancer..
03/4/202407:30PRNUSIceCure Medical Reports Full Year 2023 Financial Results:..
03/4/202406:11IHMARKETNEWSU.S. Futures Dip in Pre-Market, May WTI and June Brent Crude..
02/4/202407:30PRNUSIceCure Submits FDA Regulatory Filing for New XSense™..
27/3/202407:30PRNUSIceCure Medical to Report 2023 Full Year Financial &..
19/3/202407:30PRNUSIceCure Medical Reports Positive Topline Results From ICE3..
12/3/202407:30PRNUSIceCure Receives Notice of Patent Allowance in Japan for a..
07/3/202407:30PRNUSIceCure Medical to Present at 34th Annual Oppenheimer..
04/3/202407:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/3/202407:30PRNUSIceCure's ProSense® a Promising Alternative Treatment for..
27/2/202407:00PRNUSFourth BRIIT Conference in India Features IceCure's..
26/2/202407:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/2/202407:00PRNUSStudy Using IceCure's ProSense® Treatment Results in 100%..
15/2/202407:00PRNUSIceCure's ProSense® to be Featured at Two Upcoming Medical..
30/1/202407:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202407:00PRNUSU.S. FDA Grants IceCure Medical's Appeal: Reopens De Novo..
29/1/202407:00PRNUSIceCure Medical's Breast Cryoablation Gains Prominence in..
16/1/202407:00PRNUSIceCure Medical's ProSense® Featured at Indian Society of..
12/1/202415:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/1/202415:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/1/202415:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/1/202415:05GLOBEIceCure Medical Regains Compliance with Nasdaq Minimum..
10/1/202407:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/1/202407:00PRNUSIceCure Medical CEO Issues Letter to Shareholders & Reports..
03/1/202407:00PRNUSNew Study Reports IceCure's ProSense® Boosts Immune Response..
13/12/202307:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/12/202307:00PRNUSStudy Using IceCure's ProSense® Finds: "Cryoablation Allows..
29/11/202307:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202307:00PRNUSIceCure's ProSense® Deepens Regulatory Approval in India
28/11/202307:00PRNUSIceCure System Successfully Treated Kidney Cancer Tumor with..
15/11/202307:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202307:00PRNUSIceCure Medical Reports Financial Results as of and for the..
15/11/202306:30PRNUSIceCure Medical Files Appeal with U.S. FDA Requesting a..
08/11/202307:00PRNUSIceCure Medical to Report Third Quarter 2023 Financial &..
06/11/202307:00PRNUSSubstantial Evidence-Based Data Currently Being Generated by..
03/11/202315:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/11/202315:00PRNUSIceCure Medical Announces Receipt of Nasdaq Minimum Bid..
30/10/202307:00PRNUSIceCure's ICE3 Trial Results Demonstrating 96.91% Recurrence..
25/10/202307:00PRNUSIndependent Scientific Paper by Doctors Using IceCure's..
05/10/202307:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/10/202307:00PRNUSWomen Deemed Inoperable for Breast Cancer Benefitted from..
02/10/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/10/202307:00PRNUSIndependent Study Validates IceCure's ProSense Cryoablation..
22/9/202307:00PRNUSRenowned Spanish Radiologist Lucía Graña-López to Present..
20/9/202306:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/9/202306:00PRNUSIceCure Medical Receives FDA Response to De Novo..
08/9/202307:00PRNUSIceCure Medical to Join Hands-On Cryoablation Session with..
05/9/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Su Consulta Reciente

NASDAQ
ICCM
IceCure Medical
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados